Chordate Medical Holding AB is a medical technology company. It engages in the provision of developed, patented, and CE-marked product systems for neurostimulation treatment for the indications chronic migraine and chronic nasal congestion. The company was founded in February 2014 and is headquartered in Kista, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company